Latest news

News archive

Intervju med vd Andreas Bhagwani

13 March, 2020

Nanologicas vd Andreas Bhagwani intervjuades igår av Erik Penser Bank gällande den pågående nyemissionen. Klick på denna länk för att se intervjun.

Vd Andreas Bhagwani presenterar Nanologica på Börsveckans småbolagsdag

19 February, 2020

Den 19 februari kl 10.45 presenterar vd Andreas Bhagwani Nanologica på Börsveckans småbolagsdag. Sändningen går att följa live eller ses i efterhand via länken: Nanologica presenterar vid Börsveckans småbolagsdag

Nanologica presenterar på Börsveckans småbolagsdag 19 feb

13 February, 2020

Nanologica presenterar på Börsveckans småbolagsdag den 19 februari kl 10.45. Presentationen kan ses via länken https://tv.streamfabriken.com/2020-02-19-nanologica Anmälan att delta vid evenemanget görs via denna länk: https://financialhearings.com/event/11337

Nanologicas delårsrapport jan-mar 2017

19 May, 2017

Nanologica delårsrapport jan-mars 2017

Nanologica is a Swedish life science tools company that develops, manufactures, and sells advanced consumables to pharmaceutical manufacturers. Nanologica’s products are specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues. Due to effective purification and a long lifetime for the products, they can increase productivity and reduce costs for pharmaceutical manufacturers. Nanologica operates in a global niche market that is growing as a result of increased demand for drugs for the treatment of diabetes and obesity. The company’s mission is to increase access to cost-effective drugs through its purification products and thereby contribute to more patients around the world having access to life-saving treatments. The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.